Associations of vigorous physical activity with all-cause, cardiovascular and cancer mortality among 64 913 adults
| Autor: | Debbie Chia, Klaus Gebel, Juan Pablo Rey Lopez, Emmanuel Stamatakis |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Medicine (General)
medicine.medical_specialty Physical activity physical activity Physical Therapy Sports Therapy and Rehabilitation Disease 030204 cardiovascular system & hematology Health benefits 03 medical and health sciences R5-920 0302 clinical medicine longevity Epidemiology medicine Orthopedics and Sports Medicine 030212 general & internal medicine Cancer mortality Health Survey for England exercise business.industry Cancer medicine.disease non-communicable diseases cardio-protection Original Article business All cause mortality Demography |
| Zdroj: | BMJ Open Sport — Exercise Medicine BMJ Open Sport & Exercise Medicine, Vol 5, Iss 1 (2019) |
| ISSN: | 2055-7647 |
| Popis: | Background Physical activity recommendations state that for the same energy expenditure, moderate-to-vigorous physical activities (MVPAs) produce similar health benefits. However, few epidemiological studies have tested this hypothesis. Design We examined whether, compared with moderate, vigorous activity was associated with larger mortality risk reductions. Methods Data from 11 cohorts of the Health Survey for England and the Scottish Health Survey, collected from 1994 to 2011 (mean (SD) follow-up, 9.0 (3.6) years). Adults aged ≥30 years reported MVPA and linkage to mortality records. Exposure was the proportion of self-reported weighted MVPA through vigorous activity. Outcomes were all-cause, cardiovascular disease (CVD) and cancer mortality. Results Among 64 913 adult respondents (44% men, 56% women, mean (SD) age, 49.8 (13.6) years), there were 5064 deaths from all-causes, 1393 from CVD and 1602 from cancer during 435 743 person-years of follow-up. Compared with those who reported no vigorous physical activity, and holding constant the volume of weighted MVPA, vigorous activity was associated with additional reductions in mortality risk. For all-cause mortality, the adjusted HR was HR=0.84 (95% CI 0.71, 0.99) and HR=0.84 (95% CI 0.76, 0.94) among those who reported between >0% and |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|